Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Personalized treatment is crucial for women with hyperandrogenism-related acne and hirsutism.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Hyperandrogenism in women often causes acne and excess hair, treatable with personalized plans including weight loss, hair removal, and medications.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.